Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Go back to Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
CORMEDIX, Inc. (NASDAQ: CRMD) Delayed: 8.43 -0.04 (0.47%)
Previous Close $8.47    52 Week High $4.54 
Open $8.45    52 Week Low $1.15 
Day High $8.61    P/E N/A 
Day Low $8.31    EPS $-0.55 
Volume 792,913